Ignite Creation Date:
2024-05-06 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 12:52 PM
Study NCT ID:
NCT03641976
Status:
UNKNOWN
Last Update Posted:
2020-10-19
First Post:
2018-08-20
Brief Title:
A Study of Bevacizumab Infusional Fluorouracil Leucovorin Oxaliplatin and Irinotecan A-FOLFOXIRI Compared With Bevacizumab Infusional Fluorouracil Leucovorin and IrinotecanOxaliplatin A-FOLFIRIFOLFOX as First-line Treatment for Metastatic Right-sided Colon Cancer
Sponsor:
Yonsei University
Organization:
Yonsei University
Organization Data
Organization:
Yonsei University
Class:
OTHER
Study ID:
4-2018-0460
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Yonsei University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None